Chattanooga Center for Neurologic Research

Chattanooga, Tennessee 97401

1 studies enrolling now · 15 studies all time

What they study most

Acute Ischemic Stroke, Acute Stroke, Arm Paralysis, Atrial Fibrillation, Brain Infarction, Cardioembolic Stroke, Cerebral Ischemia, Chronic Stroke, Hemiparesis, Ischemic Stroke, Middle Cerebral Artery Stroke, Out of Hospital Cardiac Arrest

Studies at this site

• Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) — Recruiting now
• A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS — Completed
• Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy — Completed
• A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects — Completed
• Tenecteplase in Stroke Patients Between 4.5 and 24 Hours — Completed
• Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke — Completed
• Investigation of Neural Stem Cells in Ischemic Stroke — Stopped early
• Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke — Completed
• Ischemia Care Biomarkers of Acute Stroke Etiology (BASE) — Completed
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early
• COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest — Completed
• Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke — Stopped early
• Study to Examine the Effects of MultiStem in Ischemic Stroke — Completed
• Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy — Completed
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early